Director, CEO and CFO, 10% Owner · Greenwich LifeSciences, Inc. · Common Stock
Side
BUY
Value
$39K
Shares
4,600
Price
$8.37
Executed
Nov 25, 2025
Disclosed
Nov 28, 2025
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Nov 25 executedNov 28, 2025 disclosed
GLSI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · GLSI
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Patel Snehal filed this Form 4 reporting a open-market purchase of GLSI on Nov 25, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO and CFO, 10% Owner
Patel Snehalcik:0001806920
Issuer
Greenwich LifeSciences, Inc.cik:0001799788
Revision history · 0
No field has changed since this record was first ingested.
